BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1716382)

  • 1. Potentiation of BrCCl3 hepatotoxicity by chlordecone: biochemical and ultrastructural study.
    Faroon OM; Henry RW; Soni MG; Mehendale HM
    Toxicol Appl Pharmacol; 1991 Sep; 110(2):185-97. PubMed ID: 1716382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bromotrichloromethane hepatotoxicity. The role of stimulated hepatocellular regeneration in recovery: biochemical and histopathological studies in control and chlordecone pretreated male rats.
    Faroon OM; Mehendale HM
    Toxicol Pathol; 1990; 18(4 Pt 2):667-77. PubMed ID: 1709515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of bromotrichloromethane hepatotoxicity and lethality by chlordecone preexposure in the rat.
    Agarwal AK; Mehendale HM
    Fundam Appl Toxicol; 1982; 2(4):161-7. PubMed ID: 6193023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perturbations in polyamines and related enzymes following chlordecone-potentiated bromotrichloromethane hepatotoxicity.
    Rao SB; Young RA; Mehendale HM
    J Biochem Toxicol; 1990; 5(1):23-32. PubMed ID: 1698228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PB-PK derived metabolic constants, hepatotoxicity, and lethality of BrCCl3 in rats pretreated with chlordecone, phenobarbital, or mirex.
    Thakore KN; Gargas ML; Andersen ME; Mehendale HM
    Toxicol Appl Pharmacol; 1991 Jul; 109(3):514-28. PubMed ID: 1712992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection from chlordecone-amplified carbon tetrachloride toxicity by cyanidanol: biochemical and histological studies.
    Soni MG; Mehendale HM
    Toxicol Appl Pharmacol; 1991 Mar; 108(1):46-57. PubMed ID: 1706539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered hepatic energy status in chlordecone (Kepone)-potentiated CCl4 hepatotoxicity.
    Kodavanti PR; Kodavanti UP; Mehendale HM
    Biochem Pharmacol; 1990 Aug; 40(4):859-66. PubMed ID: 1696822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pivotal role of hepatocellular regeneration in the ultimate hepatotoxicity of CCl4 in chlordecone-, mirex-, or phenobarbital-pretreated rats.
    Kodavanti PR; Kodavanti UP; Faroon OM; Mehendale HM
    Toxicol Pathol; 1992; 20(4):556-69. PubMed ID: 1284994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatotoxicity and lethality of halomethanes in Mongolian gerbils pretreated with chlordecone, phenobarbital or mirex.
    Cai Z; Mehendale HM
    Arch Toxicol; 1991; 65(3):204-12. PubMed ID: 1711308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection from chlordecone-amplified carbon tetrachloride toxicity by cyanidanol: regeneration studies.
    Soni MG; Mehendale HM
    Toxicol Appl Pharmacol; 1991 Mar; 108(1):58-66. PubMed ID: 1706540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of calcium homeostasis leads to progressive phase of chlordecone-potentiated carbon tetrachloride hepatotoxicity.
    Kodavanti PR; Rao VC; Mehendale HM
    Toxicol Appl Pharmacol; 1993 Sep; 122(1):77-87. PubMed ID: 7690997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amplified interactive toxicity of chemicals at nontoxic levels: mechanistic considerations and implications to public health.
    Mehendale HM
    Environ Health Perspect; 1994 Nov; 102 Suppl 9(Suppl 9):139-49. PubMed ID: 7535226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of halomethane hepatotoxicity by chlordecone: a hypothesis for the mechanism.
    Mehendale HM
    Med Hypotheses; 1990 Dec; 33(4):289-99. PubMed ID: 1708849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of halomethane hepatotoxicity: chlordecone and carbon tetrachloride.
    Mehendale HM
    Fundam Appl Toxicol; 1984 Jun; 4(3 Pt 1):295-308. PubMed ID: 6204898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine triphosphate protection of chlordecone-amplified CCl4 hepatotoxicity and lethality.
    Soni MG; Mehendale HM
    J Hepatol; 1994 Feb; 20(2):267-74. PubMed ID: 7516359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of the lethal interaction of chlordecone and CCl4 at non-toxic doses.
    Mehendale HM
    Toxicol Lett; 1989 Dec; 49(2-3):215-41. PubMed ID: 2481348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection of chlordecone-potentiated carbon tetrachloride hepatotoxicity and lethality by partial hepatectomy.
    Bell AN; Young RA; Lockard VG; Mehendale HM
    Arch Toxicol; 1988 Apr; 61(5):392-405. PubMed ID: 2456051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-related susceptibility to chlordecone-potentiated carbon tetrachloride hepatotoxicity and lethality is due to hepatic quiescence.
    Dalu A; Warbritton A; Bucci TJ; Mehendale HM
    Pediatr Res; 1995 Aug; 38(2):140-8. PubMed ID: 7478807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chlordecone-induced potentiation of carbon tetrachloride hepatotoxicity: a light and electron microscopic study.
    Lockard VG; Mehendale HM; O'Neal RM
    Exp Mol Pathol; 1983 Oct; 39(2):230-45. PubMed ID: 6194012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of hepatocellular regeneration in chlordecone potentiated hepatotoxicity of carbon tetrachloride.
    Kodavanti PR; Joshi UM; Young RA; Bell AN; Mehendale HM
    Arch Toxicol; 1989; 63(5):367-75. PubMed ID: 2479360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.